Opportunity
Simpler Grants.gov #PAR-27-056
NIH IDeA Clinical & Translational Research (CTR) Program Funding Opportunity
Buyer
National Institutes of Health
Posted
August 19, 2026
Respond By
May 30, 2029
Identifier
PAR-27-056
NAICS
541715
This opportunity from the National Institutes of Health (NIH) aims to strengthen biomedical research in states with historically low NIH funding through the Institutional Development Award (IDeA) Clinical & Translational Research (CTR) program. - Government Buyer: - National Institutes of Health (NIH) - Program Overview: - Two tracks available: - IDeA CTR Development (CTR-D): Focuses on workforce development and infrastructure enhancement for health research organizations with limited clinical research capacity - IDeA CTR Network (CTR-N): Supports statewide or multi-state networks to expand infrastructure and coordinate clinical research activities - Eligibility: - Open to educational institutions, government entities, nonprofits, and businesses in IDeA-eligible states - Only one active award per state; lead organizations must have externally-funded clinical and translational research - Products/Services Requested: - Biomedical research capacity development services - Network expansion and coordination of clinical research activities - Unique Requirements: - Strict eligibility rules regarding participation and state award limits - No specific OEMs or vendors named; this is a grant opportunity for eligible organizations
Description
This funding opportunity supports the development of biomedical research capacity in states with historically low NIH funding through the IDeA Clinical & Translational Research (CTR) program. It offers two programmatic tracks: CTR Development, focusing on workforce development and infrastructure enhancement, and CTR Network, supporting statewide or multi-state networks to expand infrastructure and coordinate research activities. Eligible applicants include a wide range of educational, governmental, nonprofit, and business organizations located in IDeA-eligible states. Applications will be peer-reviewed, and only meritorious applications will be considered. The response due date is May 30, 2029.